NASDAQ: NKGN - NKGen Biotech, Inc.

Yield per half year: -41.05%
Dividend yield: 0.00%
Sector: Healthcare

Reporting NKGen Biotech, Inc.

Capitalization

IFRS
Reporting Annual Quarterly
2021 2022 2023 LTM 5 year average CAGR 5
ΠšΠ°ΠΏΠΈΡ‚Π°Π»ΠΈΠ·Π°Ρ†ΠΈΡ, ΠΌΠ»Ρ€Π΄ $
0.1461 0.2097 0.1838
Π’Ρ‹Ρ€ΡƒΡ‡ΠΊΠ°, ΠΌΠ»Ρ€Π΄ $
0.000426 0.0001
Чистая ΠΏΡ€ΠΈΠ±Ρ‹Π»ΡŒ, ΠΌΠ»Ρ€Π΄ $
-0.0233 -0.0268 -0.083 -0.083
EV, ΠΌΠ»Ρ€Π΄ $
0.3028 0.0752 0.0634 0.0631
EBIT, ΠΌΠ»Ρ€Π΄ $
-0.0219 -0.0244 -0.0297 -0.0297
EBITDA, ΠΌΠ»Ρ€Π΄ $
-0.0207 -0.0232 -0.0285 -0.0285
Баланс ΡΡ‚ΠΎΠΈΠΌΠΎΡΡ‚ΡŒ, ΠΌΠ»Ρ€Π΄ $
-0.0381 0.0016 -0.0587 -0.0404
FCF, ΠΌΠ»Ρ€Π΄ $
-0.02 -0.0227 -0.022 -0.022
ΠžΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½Ρ‹ΠΉ Π΄Π΅Π½Π΅ΠΆΠ½Ρ‹ΠΉ ΠΏΠΎΡ‚ΠΎΠΊ, ΠΌΠ»Ρ€Π΄ $
-0.0195 -0.0226 -0.0219 -0.0219
ΠžΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½Π°Ρ ΠΏΡ€ΠΈΠ±Ρ‹Π»ΡŒ, ΠΌΠ»Ρ€Π΄ $
-0.0219 -0.0243 -0.0297 -0.0297
ΠžΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½Ρ‹Π΅ расходы, ΠΌΠ»Ρ€Π΄ $
0.0223 0.0244 0.0285 0.0285
CAPEX, ΠΌΠ»Ρ€Π΄ $
0.000459 0.000163 0.0000 0.0000


Balance sheet

IFRS
Reporting Annual Quarterly
2021 2022 2023 LTM 5 year average CAGR 5
ΠΠ°Π»ΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ, ΠΌΠ»Ρ€Π΄ $
0.000351 0.000117 0.0000 0.000276
Total Receivables $
0.0001 0.0001 0.0000 0.0000
Total Current Assets $
0.000612 0.00035 0.0019 0.0019
ЧистыС Π°ΠΊΡ‚ΠΈΠ²Ρ‹, ΠΌΠ»Ρ€Π΄ $
0.0174 0.0159
Активы, ΠΌΠ»Ρ€Π΄ $
0.0181 0.0163 0.0165 0.0348
Short Term Debt $
0.0512 0.012 0.01 0.01
Long Term Debt $
0.0099 0.0099
Π—Π°Π΄ΠΎΠ»ΠΆΠ΅Π½Π½ΠΎΡΡ‚ΡŒ, ΠΌΠ»Ρ€Π΄ $
0.0561 0.0148 0.0752 0.0752
Чистый Π΄ΠΎΠ»Π³, ΠΌΠ»Ρ€Π΄ $
0.0508 0.0119 0.0199 0.0196
Π”ΠΎΠ»Π³, ΠΌΠ»Ρ€Π΄ $
0.052 0.012 0.0199 0.0199
Расходы Π½Π° обслуТиваниС Π΄ΠΎΠ»Π³Π° $
0.0013 0.0023 0.000745 0.000745
Чист. ΠΏΡ€ΠΎΡ†. Π΄ΠΎΡ…ΠΎΠ΄Ρ‹, ΠΌΠ»Ρ€Π΄ $
-0.0013 -0.0023 -0.000745
Амортизация, ΠΌΠ»Ρ€Π΄ $
0.0012 0.0012 0.0012 0.0012
Π‘Π΅Π±Π΅ΡΡ‚ΠΎΠΈΠΌΠΎΡΡ‚ΡŒ, ΠΌΠ»Ρ€Π΄ $
0.0000 0.0000 0.0012 0.0012
Π’ΠΎΠ²Π°Ρ€Π½ΠΎ ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½Ρ‹Π΅ запасы $
0.000172 0.000133 0.00025


Share

IFRS
Reporting Annual Quarterly
2021 2022 2023 2024 LTM 5 year average CAGR 5
EPS -0.8945 -4.21 -5.38 -5.38
Π¦Π΅Π½Π° Π°ΠΊΡ†ΠΈΠΈ Π°ΠΎ 9.74 9.95 2.75 0.7133 0.7133
Число Π°ΠΊΡ†ΠΈΠΉ Π°ΠΎ, ΠΌΠ»Π½ 26.01 6.36 15.43 15.43
FCF/Π°ΠΊΡ†ΠΈΡŽ -0.7692 -3.57 -1.43 -1.43


Efficiency

IFRS
Reporting Annual Quarterly
2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 61.14 146.64 290.4 205.33 29.22
ROA, % -128.75 -155.55 -505.65 -238.56 9.39
ROS, % -5461.27 -34745.45 0 0 0 0 23.20
ROCE, % 58.03 -1538.14 129.49 73.63 35.06
Π Π΅Π½Ρ‚Π°Π± EBITDA, % -4859.39 -30170.13 31.15
Ebit margin, % -5151.41 -31741.56
Чистая Ρ€Π΅Π½Ρ‚Π°Π±, % -5461.27 -34745.45 23.20
Operation Margin, % -5131.69 -31618.18 0 0 0 0 27.00
Π”ΠΎΡ…ΠΎΠ΄Π½ΠΎΡΡ‚ΡŒ FCF, % -13.7 -10.83 -11.96


Coefficients

IFRS
Reporting Annual Quarterly
2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-6.28 -7.84 -2.22 30.88
P/BV
-6.62 40.46 -0.7412 -1.08 7.77
P/S
591.6 821.37 7.31
P/FCF
-7.3 -9.23 0 0 0 0 38.30
E/P
-0.1593 -0.1276 -0.4512 0 0 0 0.04
EV/EBITDA
-12.54 -3.24 -2.22 -2.21 24.22
EV/Ebit
-11.82 -3.08 -2.13 -2.12 -2.12 -2.12
EV/S
609.13 976.14 0 0 0 0 7.59
EV/FCF
-12.97 -3.31 -2.88 -2.87 -2.87 -2.87 44.10
Debt/EBITDA
-2.51 -0.518 -0.6979 -0.6979 -0.6979 -0.6979 2.24
Netdebt/Ebitda
-2.49 -0.513 -0.697 -0.6883 -0.6883 -0.6883 1.14
Debt/Ratio
2.88 0.7369 1.21 0.5729 0.5729 0.5729 0.23
Debt/Equity
-1.37 7.7 -0.3394 0 0 0 2.62
Debt/Net Income
-2.23 -0.4498 -0.2401 -0.2401 -0.2401 -0.2401 3.25
Π‘Π΅Ρ‚Π°
-3.65 -0.874 -2.71 -2.71 -0.62
ИндСкс ΠΠ»ΡŒΡ‚ΠΌΠ°Π½Π°
4.34 9.31 0 -5.3 -5.3 -5.3 -65.39


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Π”ΠΈΠ²ΠΈΠ΄Π΅Π½Π΄
0
Π”ΠΈΠ² Π΄ΠΎΡ…ΠΎΠ΄, Π°ΠΎ, %
0 1.85


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe